GO:0160153 mitochondrial tRNA pseudouridine(27/28) synthase activity

Mitochondrial tRNA pseudouridine(27/28) synthase activity (GO:0160153) is a molecular function that introduces pseudouridine modifications at positions 27 and 28 of mitochondrial tRNAs. Pseudouridine (Ψ) is the most abundant post-transcriptional RNA modification, and its presence in the anticodon loop or core region of tRNAs influences structural stability and codon recognition. This activity is critical for maintaining the fidelity and efficiency of mitochondrial translation, as mitochondrial tRNAs are essential for the synthesis of oxidative phosphorylation subunits. Researchers study this term to understand mitochondrial gene expression and its implications in human disease. The enzyme catalyzing this reaction, a pseudouridine synthase, is conserved across eukaryotes. In Saccharomyces cerevisiae, the Pus3 (Deg1) protein was characterized as a pseudouridine synthase that modifies tRNA at positions 38 and 39, providing a paradigm for understanding related mitochondrial enzymes. Although the exact human mitochondrial enzyme for positions 27/28 is not fully defined in the provided literature, the functional annotation GO:0160153 captures this specific catalytic step. Given the rising interest in mitochondrial dysfunction in cancer, neurodegeneration, and rare genetic disorders, precise annotation of GO:0160153 is vital for interpreting omics data and designing targeted experiments.

GO:0160153 is defined as the catalysis of the reaction: uridine(27/28) in mitochondrial tRNA = pseudouridine(27/28) in mitochondrial tRNA. In other words, it is the enzymatic activity that isomerizes uridine to pseudouridine at positions 27 and 28 within mitochondrial tRNA molecules, a modification that affects tRNA structure and function.

GO:0160153 is important because pseudouridine modification at positions 27/28 is crucial for the structural integrity and decoding function of mitochondrial tRNAs. Proper tRNA modification ensures efficient mitochondrial protein synthesis, which is indispensable for cellular energy metabolism. Dysregulation of this activity has been associated with mitochondrial diseases and may contribute to broader pathologies such as neurodegeneration and cancer.

The following genes and proteins are associated with pseudouridine synthase activity and mitochondrial tRNA modification, based on experimental evidence from model organisms and bioinformatic predictions.

The regulation of mitochondrial tRNA pseudouridine(27/28) synthase activity is not well characterized in the provided literature. However, general principles of tRNA modification enzyme regulation may apply, including transcriptional control, post-translational modifications, and availability of cofactors. Further research is needed to elucidate specific regulatory mechanisms.

Defects in mitochondrial tRNA modification, including pseudouridylation, have been linked to mitochondrial diseases such as encephalomyopathies and cardiomyopathies. Mutations in genes encoding tRNA modification enzymes can impair mitochondrial translation and lead to multi-system disorders.

Altered pseudouridine synthase expression has been observed in various cancers, suggesting a role in tumorigenesis. Dysregulation of mitochondrial tRNA modifications may affect metabolic reprogramming in cancer cells.

Mitochondrial dysfunction is a hallmark of neurodegenerative diseases. Impaired tRNA pseudouridylation could contribute to neuronal death by disrupting mitochondrial energy production.

RNA-seq and specialized techniques like Ψ-seq or Pseudo-seq can map pseudouridine sites in mitochondrial tRNA. These methods allow researchers to assess the impact of synthase knockout or mutations on tRNA modification patterns.

Mitochondrial protein synthesis can be measured using radioactive labeling or ribosome profiling. These assays help determine how loss of pseudouridine(27/28) affects mitochondrial translation efficiency.

Mass spectrometry-based proteomics can identify proteins interacting with the synthase. Affinity purification followed by mass spectrometry reveals the composition of the modification complex.

Fluorescence microscopy and Seahorse extracellular flux analysis can assess mitochondrial morphology and function in cells lacking the synthase activity.

Researchers studying mitochondrial tRNA pseudouridine(27/28) synthase activity-related genes often need to determine whether a candidate gene is causally involved in mitochondrial function and disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.

GO:0160153, mitochondrial tRNA pseudouridine(27/28) synthase activity, represents a critical RNA modification step in mitochondrial biology. Understanding its mechanism and regulation can illuminate mitochondrial disease pathogenesis and reveal new therapeutic targets. Leveraging CRISPR technologies and EDITGENE's services will accelerate discoveries in this field.